1. Home
  2. ARVN vs BMBL Comparison

ARVN vs BMBL Comparison

Compare ARVN & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • BMBL
  • Stock Information
  • Founded
  • ARVN 2015
  • BMBL 2014
  • Country
  • ARVN United States
  • BMBL United States
  • Employees
  • ARVN N/A
  • BMBL N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • BMBL Computer Software: Prepackaged Software
  • Sector
  • ARVN Health Care
  • BMBL Technology
  • Exchange
  • ARVN Nasdaq
  • BMBL Nasdaq
  • Market Cap
  • ARVN 456.2M
  • BMBL 446.5M
  • IPO Year
  • ARVN 2018
  • BMBL 2021
  • Fundamental
  • Price
  • ARVN $7.53
  • BMBL $5.31
  • Analyst Decision
  • ARVN Buy
  • BMBL Hold
  • Analyst Count
  • ARVN 21
  • BMBL 15
  • Target Price
  • ARVN $20.53
  • BMBL $6.56
  • AVG Volume (30 Days)
  • ARVN 2.2M
  • BMBL 2.8M
  • Earning Date
  • ARVN 07-29-2025
  • BMBL 05-07-2025
  • Dividend Yield
  • ARVN N/A
  • BMBL N/A
  • EPS Growth
  • ARVN N/A
  • BMBL N/A
  • EPS
  • ARVN N/A
  • BMBL N/A
  • Revenue
  • ARVN $426,900,000.00
  • BMBL $1,050,969,000.00
  • Revenue This Year
  • ARVN $2.83
  • BMBL N/A
  • Revenue Next Year
  • ARVN N/A
  • BMBL N/A
  • P/E Ratio
  • ARVN N/A
  • BMBL N/A
  • Revenue Growth
  • ARVN 498.74
  • BMBL N/A
  • 52 Week Low
  • ARVN $5.90
  • BMBL $3.55
  • 52 Week High
  • ARVN $34.11
  • BMBL $11.81
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 54.38
  • BMBL 47.85
  • Support Level
  • ARVN $6.70
  • BMBL $5.16
  • Resistance Level
  • ARVN $7.60
  • BMBL $5.53
  • Average True Range (ATR)
  • ARVN 0.45
  • BMBL 0.25
  • MACD
  • ARVN 0.15
  • BMBL -0.11
  • Stochastic Oscillator
  • ARVN 95.04
  • BMBL 13.64

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.

Share on Social Networks: